References

Bayliss, C.D., R.W. Peters, J.K. Cook, R.L. Reece, K. Howes, M.M. Binns and M.E. Boursnell, 1991. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol., 120: 193-205.
PubMed  |  

Bayliss, C.D., U. Spies, K. Shaw, R.W. Peters, A. Papageorgiou, H. Muller and M.E.G. Boursnell, 1990. A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. J. Gen. Virol., 71: 1303-1312.
PubMed  |  Direct Link  |  

Birghan, C., E. Mundt and A.E. Gorbalenya, 2000. A non-canonical Lon proteinase deficient of the ATPase domain employs the Ser-Lys catalytic dyad to impose broad control over the life cycle of a double-stranded RNA virus. J. EMBO, 19: 114-123.

Brown, F., 1986. The classification and nomenclature of viruses. Int. Committee Taxon. Viruses Intervirol., 25: 141-143.
CrossRef  |  

Chang, H.C., T.L. Lin and C.C. Wu, 2001. DNA-mediated vaccination against infectious bursal disease in chickens. Vaccine, 20: 328-335.
CrossRef  |  Direct Link  |  

Chang, H.C., T.L. Lin and C.C. Wu, 2003. DNA vaccination with plasmids containing various fragments of large segment genome of infectious bursal disease virus. Vaccine, 21: 507-513.
CrossRef  |  

Chaplin, P.J., R. De, J.S. Boyle, P. McWaters and J. Kelly et al., 1999. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun., 67: 6434-6438.
PubMed  |  

Degen, W.G.J., H.I. van Zuilekom, N.C. Scholtes, N.van Daal and V.E.J.C. Schijns, 2005. Potentiation of humoral immune responses to vaccine antigens by recombinant chicken IL-18 (rChIL-18). Vaccine, 23: 4212-4218.
CrossRef  |  

Fahey, K.J., K. Erny and J. Crooks, 1989. A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J. Gen. Virol., 70: 1473-1481.
CrossRef  |  Direct Link  |  

Fodor, I., E. Horvath, N. Fodor, E. Nagy, A. Rencendorsh, V.N. Vakharia and S.K. Dube, 1999. Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens. J. Acta Veterinaria Hungarica, 47: 481-492.
CrossRef  |  PubMed  |  Direct Link  |  

Gao, Y.L., H.L. Gao, X.Y. Wang, J.S. Li and X.Y. Deng et al., 2007. Immunogenicity of recombinant VP2 protein of infectious bursal disease virus expressed in recombinant baculoviruses. Chinese J. Preventive Veterinary Med., 29: 427-431.

Giambrone, J.J. and J. Closser, 1990. Efficacy of live vaccines against serologic subtypes of infectious bursal disease virus. Avian Dis., 34: 7-11.
PubMed  |  

Giambrone, J.J., C.S. Eidson, R.K.Page, O.J. Flitcher, B.O. Barger and S.H. Kleven, 1976. Effects of infectious bursal disease agent on the response of chickens to Newcastle disease and Marek's disease vaccination. Avian Dis., 20: 534-544.

Hanke, T., T.J. Blanchard, J. Schneider, C.M. Hannan and M. Becker et al., 1998. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regimen. Vaccine, 16: 439-445.
CrossRef  |  

Hayer-Hart, M.K., F. Weber and F.U. Hartl, 1996. Mechanism of chaperonin action: GroES binding and release can drive GroEL-mediated protein folding in the absence of ATP hydrolysis. EMBO J., 15: 6111-6121.
PubMed  |  

Hu, Y.C., Y.L. Luo, W.T. Ji, J.L.C. Chulu and P.C. Chang et al., 2006. Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus system. J. Virol. Methods, 135: 43-48.
CrossRef  |  

Hung, L.H., H.P. Li, Y.Y. Lien, M.L. Wu and H.C. Chaung, 2010. Adjuvant effects of chicken interleukin-18 in avian Newcastle disease vaccine. Vaccine, 28: 1148-1155.
CrossRef  |  Direct Link  |  

Jiang, Y.G. and Z.S. Li, 2003. The effect and mechanism of Interleukin-18 in hepatic lesion. J. Live, 8: 49-50.

Kent, S.J., A. Zhao, S.J. Best, J.D. Chandler, D.B. Boyle and I.A. Ramshaw, 1998. Enhanced T cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol., 72: 10180-10188.
Direct Link  |  

Macreadie, I.G., P.R. Vaughan, A.J. Chapman, N.M. Mckern and M.N. Jagadish et al., 1990. Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine, 8: 549-552.
CrossRef  |  Direct Link  |  

Mahmood, M.S., I. Hussain, M. Siddique, M. Akhtar and S. Ali, 2007. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5α given orally confers protective immune responses in chickens. Vaccine, 25: 7629-7635.
PubMed  |  

Majo, N., J. El-Attrache, A. Banda, P. Villegas, A. Ramis, A Pages and N. Ikuta, 2002. Molecular characterization of Spanish infectious bursal disease virus field isolates. Avian Dis., 46: 859-868.
PubMed  |  

Marshall, D.J., K.A. Rudnick and S.G. McCarthy, 2006. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine, 24: 244-253.
PubMed  |  

Noll, A. and I.B. Autenrieth, 1996. Immummunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 plus interleukin-12. Infect Immun., 64: 2955-2961.
PubMed  |  

Oveissi, S., A.R. Omar, K. Yusoff, F. Jahanshiri and S.S. Hassan, 2010. DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens. Comp. Immunol. Microbiol. Infect. Dis., 33: 491-503.
CrossRef  |  PubMed  |  Direct Link  |  

Rong, J., T. Jiang, T. Cheng, M. Shen and Y. Du et al., 2007. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens. Vaccine, 25: 7900-7908.
CrossRef  |  

Rong, J., X.N. Liu and T.P. Cheng, 2001. Application of a Reverse Transcription Polymerase Chain Reaction (RT-PCR) for diagnosis of wild IBDV infection of chicks after to be inoculated IBDV vaccine. Chin. J. Vet. Sci. Technol., 31: 18-19.

Rothel, J.S., J.G. Waterkeyn, R.A. Strugnell, P.R. Wood, H.F. Seow, J. Vadolas and M.W. Lightowlers, 1997. Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol. Cell Biol., 75: 41-46.
PubMed  |  

Scheerlinck, J.P.Y., G. Casey, P. McWaters, J. Kelly and D. Woollard et al., 2001. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine, 19: 4053-4060.
CrossRef  |  

Schrijver, R.S., J.P. Langedijk, G.M. Keil, W.G. Middel and M. Maris-Veldhuis, et al., 1997. Immunisation of cattle with BHV1 vector vaccine or a DNA vaccine both encoding for the G protein of BRSV. Vaccine, 15: 1908-1916.
CrossRef  |  

Scott, P. and H.E. Kaufmann, 1991. The role of T cell subsets and cytokines in the regulation of infection. Immunol. Today, 12: 346-348.
PubMed  |  

Spies, U., H. Muller and H. Becht, 1989. Nucleotide sequence of infectious bursal disease virus segment A delineates two major open reading frames. Nucl. Acids Res., 17: 7982-7982.
CrossRef  |  

Stephen, P.D., J.N. Flynn and M.A. Rigby, 2002. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and-18. Vaccine, 20: 1483-1496.

Trimble, R.B., P.H. Atkinson, J.E. Tschopp, R.R. Townsend and F. Maley, 1991. Structure of oligosaccharides on saccaromyces SUC2 invertase secreted by the methylotrophic yeast Pichia pastoris. J. Biol. Chem., 266: 22807-22817.
PubMed  |  

Tsukamoto, K., C. Kojima, Y. Komori, N. Tanimuraa, M. Mase and S. Yamaguchi, 1999. Protection of chickens against very virulent Infectious Bursal Disease Virus (IBDV) and Marek's Disease Virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology, 257: 352-362.
CrossRef  |  

Van den Berg, T.P., 2000. Acute infectious bursal disease in poultry: A review. Avian Pathol., 29: 175-194.
CrossRef  |  Direct Link  |  

Wong, H.T., S.C.S. Cheng, F.W.Y. Sin, E.W.C. Chan, Z.T. Sheng and Y. Xie, 2002. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine, 20: 2641-2647.
CrossRef  |  Direct Link  |  

Wu, H., J.K. Singh, R.D. Locy, K. Scissum-Gunn and J.J. Giambrone, 2004. Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana. Biotechnol. Lett., 26: 782-792.
PubMed  |  

Yu, L., J.R. Li and Y.W. Huang, 2002. Immunogenicity study in DNA vaccine of infectious bursal disease virus. J. Scientia Agric. Sinica, 35: 995-1001.

Yu, X.M., C.B. Shou, X.D. Zhang, G.L. Xu and L. Yu, 2008. Immunoenhancement on DNA vaccine of polyprotein gene in infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin-18. J. Zhejiang Univ., 34: 13-18.